Gizmodo
This Pill Will Change Cancer Treatment Forever
Revolution Medicines' daraxonrasib is the first drug that can broadly tackle one of the main drivers of pancreatic cancer.
Via Gizmodo
·Excerpt
Revolution Medicines is the winner of the 2026 Gizmodo Science Fair for its research and development of Rasonque (daraxonrasib), the first approved cancer drug of its kind.
The question
Can we find an effective and reliable treatment for pancreatic cancer, which currently only has a five-year survival rate of 13%?
The results
In a large-scale clinical trial of 500 people with metastatic pancreatic ductal adenocarcinoma (the most common form of pancreatic cancer), people on daraxonrasib lived twice as long as…
Courtesy
This story was originally published by Gizmodo. All rights belong to the original publisher.
Read the original on gizmodo.com ↗